Review
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Mar 27, 2016; 8(3): 179-192
Published online Mar 27, 2016. doi: 10.4240/wjgs.v8.i3.179
Assessment of lymph node involvement in colorectal cancer
Mark L H Ong, John B Schofield
Mark L H Ong, John B Schofield, Department of Histopathology, Maidstone Hospital, Maidstone, Kent ME16 9QQ, United Kingdom
John B Schofield, School of Physical Sciences, University of Kent, Canterbury, Kent CT2 7NH, United Kingdom
Author contributions: Ong MLH and Schofield JB wrote and amended the paper.
Conflict-of-interest statement: The authors declare no conflicts of interest regarding this manuscript.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: John Schofield, MBBS, Professor, Consultant Histopathologist, Department of Histopathology, Maidstone Hospital, Hermitage Lane, Maidstone, Kent ME16 9QQ, United Kingdom. john.schofield@nhs.net
Telephone: +44-16-22224050 Fax: +44-16-22225774
Received: August 8, 2015
Peer-review started: August 11, 2015
First decision: September 22, 2015
Revised: October 24, 2015
Accepted: December 29, 2015
Article in press: January 4, 2016
Published online: March 27, 2016
Abstract

Lymph node metastasis informs prognosis and is a key factor in deciding further management, particularly adjuvant chemotherapy. It is core to all contemporary staging systems, including the widely used tumor node metastasis staging system. Patients with node-negative disease have 5-year survival rates of 70%-80%, implying a significant minority of patients with occult lymph node metastases will succumb to disease recurrence. Enhanced staging techniques may help to identify this subset of patients, who might benefit from further treatment. Obtaining adequate numbers of lymph nodes is essential for accurate staging. Lymph node yields are affected by numerous factors, many inherent to the patient and the tumour, but others related to surgical and histopathological practice. Good lymph node recovery relies on close collaboration between surgeon and pathologist. The optimal extent of surgical resection remains a subject of debate. Extended lymphadenectomy, extra-mesenteric lymph node dissection, high arterial ligation and complete mesocolic excision are amongst the surgical techniques with plausible oncological bases, but which are not supported by the highest levels of evidence. With further development and refinement, intra-operative lymphatic mapping and sentinel lymph node biopsy may provide a guide to the optimum extent of lymphadenectomy, but in its present form, it is beset by false negatives, skip lesions and failures to identify a sentinel node. Once resected, histopathological assessment of the surgical specimen can be improved by thorough dissection techniques, step-sectioning of tissue blocks and immunohistochemistry. More recently, molecular methods have been employed. In this review, we consider the numerous factors that affect lymph node yields, including the impact of the surgical and histopathological techniques. Potential future strategies, including the use of evolving technologies, are also discussed.

Keywords: Colorectal cancer, Lymphatic metastases, Lymph node metastasis, Neoplasm staging, Tumor node metastasis classification, Sentinel lymph node biopsy, Lymph node excision, Histopathological assessment, Surgery

Core tip: The number of lymph nodes in surgical resection specimens is influenced by numerous factors. Good practice by surgeons and pathologists is essential to maximize lymph node yields, but there are non-modifiable factors related to patient and tumour. Extended lymphadenectomy, extra-mesenteric lymph node dissection, high arterial ligation and complete mesocolic excision, all increase lymph node yields, but a definite benefit in prognosis is not proven and the optimal extent of surgical resection remains contentious. Conversely, further development in sentinel lymph node biopsy techniques could allow selective lymphadenectomy, whilst providing appropriate information to guide adjuvant therapy.